Interestingly, a recent cutaneous melanoma case–control cohort study demonstrated that the contribution of POT1 to melanoma risk burden in the general population was only 0.5% with an OR of only 2.1 (95% CI 0.89 to 5.00).14 This evidence concerns the gene POT1 and melanoma.